PCSK9 and fatty liver disease: Evidence showed that HFD could induce liver steatosis and raise both circulating and hepatic PCSK9 levels in mice.184 Research by Demers and colleagues revealed PCSK9’s ability to regulate CD36 expression, a key influencer of FA uptake and a contributing factor to liver steatosis.